AngioDynamics to Hold Fiscal 2010 First Quarter Financial Results Conference Call on October 6, 2009
QUEENSBURY, N.Y.-(Business Wire)-September 21, 2009 - AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal 2010 first quarter financial results on Tuesday, October 6, 2009, after the close of the financial markets.
Jan Keltjens, President and Chief Executive Officer, and Joseph Gersuk, Executive Vice President and CFO, will host an investment community conference call beginning at 4:30 p.m. Eastern time on October 6 to discuss these results and to answer questions.
To participate in the live call by telephone, please dial +1 (877) 941-1848 from the U.S., or for international callers, please dial +1 (480) 629-9722.
Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics’ Web site at http://investor.angiodynamics.com. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software.
A replay will be available on the Web site. A telephone replay will be available from 6:30 p.m. Eastern time on October 6, 2009, through 11:59 p.m. Eastern time on October 13 by dialing +1 (800) 406-7325 (domestic) or +1 (303) 590-3030 (international) and entering the passcode: 4159408#.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. The Company’s diverse product line includes market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
